Backgroun& Surgery for portal hypertension has a low rebleeding rate. Patients that rebleed can be grossly divided into those who die as a consequence of the episode, those who don't die but develop liver failure (remaining as Child-Pugh C) and those who, in spite of the bleeding episode, retain good liver function (Child-Pugh A or B). At our hospital, the latter group is considered for further surgical treatment. We report here the results of surgical rescue of surgical failures.
Methods; In a twenty year period, 36 patients (30 Child-Pugh A, 6 Child-Pugh B) were reoperated. The files of these patients were reviewed.
Results; Average age was 33 years. Cirrhosis was present in 31 cases. All patients were electively reoperated with portal blood flow preserving procedures. Operative mortality for the whole group was 12% and for the Child-Pugh A group 6 [2] . Portal blood flow preserving procedures (selective shunts, Sugiura-Futagawa procedure, low diameter shunts) are the preferred operation for most patients. In many centers, a low operative mortality as well as a low re-bleeding and encephalopathy rate has been achieved. There is no doubt that for low risk patients, portal blood flow preserving procedures are the treatment of choice [3] .
Re-bleeding rates after surgery are usually below 10% [4] [5] [6] [7] . Patients In Table II , the information about the failure and cause of rebleeding and the kind of the reoperation is given. Thirty cases were failures from our hospital and six cases came from other hospitals. In all instances, the reoperations [8] for evaluation of quality of life, it was good for 84% of the cases and bad for 16% of cases. Survival (Kaplan-Meier) was 78% at 6 months and 69% at 5 years. (Fig. 1) .
DISCUSSION
Among the alternatives to control variceal bleeding, surgery remains as the most effective treatment. Re-bleeding rate is low in most series. Portal blood flow preserving procedures are the preferred operations [3] . In almost all centers in which surgery is routinely performed for the treatment of bleeding portal hypertension, selection of cases has been over emphasized. If surgery is electively performed in low risk patients (Child-Pugh A), good results are to be expected. Most of these patients do well after the operation, with a good quality of life [8] .
Nevertheless, surgery has failures and there is virtually no series in which re-bleeding is not reported. For shunt surgery, the most likely cause of re-bleeding is shunt dysfunction. Selective shunts have a very low rate of obstruction and/or dysfunction [9, 10] , less than 5% in our experience. For devascularizations, the cause is more difficult to explain, but certainly in spite of interrupting afferent and afferent vessels, portal hypertension still remains in the esophagogastric area, and variceal recurrence may occur. This event is less frequent in our experience for the extensive SugiuraFutagawa devascularization.
Patients that fail to surgery have the possibility of rebleeding from other sources. This paper discusses only the patients that had rebleeding because of portal hypertension.
For patients with obstructed shunts esophagogastric varices is the most common site of rebleeding. This is particularly true for the DSRS, in which the whole esophagogastric and splenic area is drained through the shunt. For patients with devascularization procedures, gastric varices and hypertensive gastropathy represent a considerable source of bleeding. In some cases, re-bleeding has a fatal outcome. In other cases, liver function deteriorates after re-bleeding. In another subset of patients, no changes in liver function are observed and they remain as Child-Pugh A. There is no agreement on how to treat these patients. In many centers, surgical failures are treated with alternate therapeutic choices, including sclerotherapy, TIPS and liver transplantation. Sclerotherapy has a high re-bleeding rate and in our opinion should be reserved for patients with bad liver function [2] . Liver transplantation is not indicated as treatment for re-bleeding, but there is no doubt that for patients with bad liver function, it is the treatment of choice [12] , and TIPS are indicated as "a bridge" for liver transplantation and its role for long term treatment has not established yet. The high rate of dysfunction (as well as the fact that it is a non portal blood flow preserving procedure) does not make TIPS the treatment of choice for patients with good liver function [13] .
The 
